News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Pfizer Inc. (JOBS) HIV Drug Seems Safe for New Use Says FDA Staff
October 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Pfizer Inc's HIV drug Selzentry appears to be safe for wider use in patients with the disease who have not begun taking any medications yet, U.S. Food and Drug Administration staff said in a document released on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Pfizer
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Obesity
Aardvark Pauses 2 Obesity Trials, Reveals New Details on Cardiac Concerns
March 24, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint
March 23, 2026
·
2 min read
·
Heather McKenzie
Insights
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing
March 23, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Spinal muscular atrophy
Roche Ends Run for Muscular Atrophy Drug, Leaving Door Open for Competitors
March 20, 2026
·
2 min read
·
Tristan Manalac